Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Cowan

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
JAMA Oncology|November 30, 2018
Burden of Multiple Myeloma in Taiwan-ReplyAndrew J Cowan, Christina Fitzmaurice
British Journal of Haematology|November 28, 2023
Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myelomaAndrew J Cowan, Damian J Green
Clinical Genitourinary Cancer|December 3, 2014
Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamideAndrew J Cowan, Yoshio Inoue, Evan Y Yu
Frontiers in Oncology|December 12, 2022
Innovation in BCMA CAR-T therapy: Building beyond the Model TRahul Banerjee, Sarah S Lee, Andrew J Cowan
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2018
Plasma cell diseases and organ transplant: A comprehensive reviewAndrew J Cowan, Christopher K Johnson, Edward N Libby
Frontiers in Oncology|October 18, 2023
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profilingRahul Banerjee, Kara I Cicero, Sarah S Lee, et al.
JCO Clinical Cancer Informatics|January 29, 2020
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen ContentSamuel M Rubinstein, Peter C Yang, Andrew J Cowan, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicinAndrew J Cowan, George S Laszlo, Elihu H Estey, et al.
JCO Oncology Practice|January 8, 2025
Novel Treatment Options for Multiple MyelomaAndrew J Portuguese, Rahul Banerjee, GuiZhen Chen, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T Cells for Multiple Myeloma: The Journey So Far-And the Road AheadAndrew J Cowan, Sherilyn A Tuazon, Andrew J Portuguese, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
JAMA Oncology|November 30, 2018
Burden of Multiple Myeloma in Taiwan-ReplyAndrew J Cowan, Christina Fitzmaurice
British Journal of Haematology|November 28, 2023
Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myelomaAndrew J Cowan, Damian J Green
Clinical Genitourinary Cancer|December 3, 2014
Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamideAndrew J Cowan, Yoshio Inoue, Evan Y Yu
Frontiers in Oncology|December 12, 2022
Innovation in BCMA CAR-T therapy: Building beyond the Model TRahul Banerjee, Sarah S Lee, Andrew J Cowan
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2018
Plasma cell diseases and organ transplant: A comprehensive reviewAndrew J Cowan, Christopher K Johnson, Edward N Libby
Frontiers in Oncology|October 18, 2023
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profilingRahul Banerjee, Kara I Cicero, Sarah S Lee, et al.
JCO Clinical Cancer Informatics|January 29, 2020
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen ContentSamuel M Rubinstein, Peter C Yang, Andrew J Cowan, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicinAndrew J Cowan, George S Laszlo, Elihu H Estey, et al.
JCO Oncology Practice|January 8, 2025
Novel Treatment Options for Multiple MyelomaAndrew J Portuguese, Rahul Banerjee, GuiZhen Chen, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T Cells for Multiple Myeloma: The Journey So Far-And the Road AheadAndrew J Cowan, Sherilyn A Tuazon, Andrew J Portuguese, et al.
Pageof 12